Tag Archive for: clinical trials
The Biggest Psychedelic News Stories of the Week – September 11th
Business, Policy, TreatmentCalifornia stands on the cusp of a psychedelic revolution with the TREAT Act and a landmark bill on 'magic mushrooms,' even as Michigan, Congress, and global initiatives from Sweden to Canada expand the horizons of mental health, addiction treatment, and veteran care.
Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment
ResearchAside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%).
Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?
Culture, TreatmentAs an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised to greatly benefit from the diverse initiatives offered within this package.
Adverse Events in Psychedelic Clinical Trials are Underreported
ResearchNew research shows that enthusiasm for psychedelic treatments makes it easy to ignore adverse events in psychedelic clinical trials
Psychedelic Clinical Trials and the Michael Pollan Effect
Culture, ResearchWith the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on psychedelic treatments that are not yet available
Three Phase 3 Clinical Trials that Could Legalize Psychedelics
Policy, ResearchThe road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
3 Microdosing Clinical Trials to Keep an Eye On
Business, ResearchDoes microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical trials looking for answers
Psychedelic Business Spotlight – June 17
Business, News, Stock ReportsThis week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!